Hankyel Park

Array ( [id] => 6140895 [patent_doc_number] => 20020001596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Prophylactic and therapeutic method' [patent_app_type] => new [patent_app_number] => 09/793713 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3423 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20020001596.pdf [firstpage_image] =>[orig_patent_app_number] => 09793713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417883 [patent_doc_number] => 06506557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-14 [patent_title] => 'Methods and compositions for identifying a protease' [patent_app_type] => B2 [patent_app_number] => 09/792416 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7942 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506557.pdf [firstpage_image] =>[orig_patent_app_number] => 09792416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1407147 [patent_doc_number] => 06528252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Methods for identifying a protease inhibitor' [patent_app_type] => B2 [patent_app_number] => 09/791426 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 9027 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528252.pdf [firstpage_image] =>[orig_patent_app_number] => 09791426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1474189 [patent_doc_number] => 06387686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-14 [patent_title] => 'Methods and compositions for identifying a polynucleotide encoding a protease' [patent_app_type] => B2 [patent_app_number] => 09/791427 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7136 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387686.pdf [firstpage_image] =>[orig_patent_app_number] => 09791427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986630 [patent_doc_number] => 20010036462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Adjuvant treatment by in vivo activation of dendritic cells' [patent_app_type] => new [patent_app_number] => 09/791992 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4685 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036462.pdf [firstpage_image] =>[orig_patent_app_number] => 09791992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414427 [patent_doc_number] => 06518031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-11 [patent_title] => 'Hapten-carrier conjugates for treating and preventing nicotine addiction' [patent_app_type] => B2 [patent_app_number] => 09/784139 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12045 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518031.pdf [firstpage_image] =>[orig_patent_app_number] => 09784139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1407790 [patent_doc_number] => 06528287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells' [patent_app_type] => B2 [patent_app_number] => 09/782977 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7080 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528287.pdf [firstpage_image] =>[orig_patent_app_number] => 09782977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6305956 [patent_doc_number] => 20020094521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Assay for detection of viral fusion inhibitors' [patent_app_type] => new [patent_app_number] => 09/779451 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15085 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094521.pdf [firstpage_image] =>[orig_patent_app_number] => 09779451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935935 [patent_doc_number] => 20020061516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Method for detecting and for quantifying adenoviruses' [patent_app_type] => new [patent_app_number] => 09/778898 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9190 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061516.pdf [firstpage_image] =>[orig_patent_app_number] => 09778898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275749 [patent_doc_number] => 20020106637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'CELL FUSION ASSAYS FOR THE IDENTIFICATION OF ANTIVIRAL COMPOUNDS, AND SYSTEMS AND KITS FOR PRACTICING THE SAME' [patent_app_type] => new [patent_app_number] => 09/779324 [patent_app_country] => US [patent_app_date] => 2001-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6327 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106637.pdf [firstpage_image] =>[orig_patent_app_number] => 09779324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275701 [patent_doc_number] => 06645501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-11 [patent_title] => 'Anti-pathogen system and methods of use thereof' [patent_app_type] => B2 [patent_app_number] => 09/775052 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 26 [patent_no_of_words] => 30093 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645501.pdf [firstpage_image] =>[orig_patent_app_number] => 09775052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6358740 [patent_doc_number] => 20020058325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Recombinant AAV packaging systems' [patent_app_type] => new [patent_app_number] => 09/770315 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9569 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058325.pdf [firstpage_image] =>[orig_patent_app_number] => 09770315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534383 [patent_doc_number] => 06489142 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Methods and compositions for producing viral particles' [patent_app_type] => B1 [patent_app_number] => 09/700422 [patent_app_country] => US [patent_app_date] => 2001-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 11131 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489142.pdf [firstpage_image] =>[orig_patent_app_number] => 09700422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859845 [patent_doc_number] => 20020123472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Treatment of autoimmune disease' [patent_app_type] => new [patent_app_number] => 09/768769 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16621 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123472.pdf [firstpage_image] =>[orig_patent_app_number] => 09768769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097423 [patent_doc_number] => 20020052481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof' [patent_app_type] => new [patent_app_number] => 09/766995 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 25073 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052481.pdf [firstpage_image] =>[orig_patent_app_number] => 09766995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936940 [patent_doc_number] => 20020062016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Detection of Human Immunodeficiency Virus type 1' [patent_app_type] => new [patent_app_number] => 09/766095 [patent_app_country] => US [patent_app_date] => 2001-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5671 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20020062016.pdf [firstpage_image] =>[orig_patent_app_number] => 09766095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370198 [patent_doc_number] => 06562594 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Saturation mutagenesis in directed evolution' [patent_app_type] => B1 [patent_app_number] => 09/756459 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34075 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562594.pdf [firstpage_image] =>[orig_patent_app_number] => 09756459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476009 [patent_doc_number] => 20020151679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Alloferons - immunomodulatory peptides' [patent_app_type] => new [patent_app_number] => 09/748114 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8753 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151679.pdf [firstpage_image] =>[orig_patent_app_number] => 09748114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828204 [patent_doc_number] => 20020068271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Methods for identifying agents capable of modulating protein kinase C theta (PKC0) activity' [patent_app_type] => new [patent_app_number] => 09/749956 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13015 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068271.pdf [firstpage_image] =>[orig_patent_app_number] => 09749956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876528 [patent_doc_number] => 20010006681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'Chemokine inhibition of immunodeficiency virus' [patent_app_type] => new-utility [patent_app_number] => 09/747142 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23873 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006681.pdf [firstpage_image] =>[orig_patent_app_number] => 09747142 [rel_patent_id] =>[rel_patent_doc_number] =>)